Ophthalmic gel for treating myopia

Abstract

The invention relates to an ophthalmic gel for treating myopia. The ophthalmic gel is prepared from the following raw materials in parts by weight: 200-300 parts of dactylicapnos scandens alkaloid (dactylicapnos scandens extract), 200-300 parts of borneol and the balance of sodium chloride injection water or ophthalmic gel.

Description

technical field [0001] The present invention relates to the technical field of ophthalmic preparations, in particular to an ophthalmic gel for treating myopia. Background technique [0002] According to the data, the proportion of myopia among primary school students in my country is 45.7%, that of junior high school students is 74.4%, and that of high school students is 83.3%. At present, the total incidence of myopia in my country accounts for more than 53% of the total population. younger age trend. The myopia rate and total number of children and adolescents in China ranks first in the world. [0003] Many hospitals have also found through research and clinical findings that myopia is closely related to long-term and short-distance eye use. Some literature materials point out that more than 80% of young people's myopia is caused by excessive use of eyes at close range. Because the ciliary muscle inside the human eye is connected to the lens through the suspensory ligame...

AI Technical Summary

Problems solved by technology

[0005] Some current treatments are not effective enough

The abuse of antibiotics and preservatives will affect the normal physiological environment of the eyes to a certain extent, destroy the stability of the tear film on the ocular surface, interfere with the normal metabolism of the corneal epithelium, and even aggravate the original condition, resulting in punctate scars and erosion of the corneal epithelium , and even cause vision loss